MedTrace Logo

Evaluation of Retinal Structure With High Resolution Optical Coherence Tomography (OCT)

NCT00564291 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2023-11-29

No results posted yet for this study

Summary

Comparison of different OCT instruments to assess retinal thickness, correlation to fluorescein angiography, and visual outcome after therapy with anti-VEGF therapy

Conditions

  • Macular Edema
  • CNV

Interventions

OTHER

Examination with an OCT device

Sponsors & Collaborators

  • University of Bern

    collaborator OTHER

  • Sebastian Wolf

    lead OTHER

Principal Investigators

  • Sebastian Wolf, MD, PhD · University of Bern

  • Sebastian Wolf, MD PhD · University of Bern

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2023-11-27
Completion
2023-11-28

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00564291 on ClinicalTrials.gov